Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients

Although α-glucosidase inhibitors (AGIs) are commonly used for controlling postprandial blood glucose, AGIs-induced liver injuries have been reported. However, the relationship between AGIs and liver injuries in advanced chronic kidney disease (CKD) patients remains unexplored. In this nationwide ca...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Kao, Chih-Chin, Wu, Pei-Chen, Wu, Che-Hsiung, Chen, Li-kwang, Chen, Hsi-Hsien, Wu, Mai-Szu, Wu, Vin-Cent
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2016
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707434/
https://ncbi.nlm.nih.gov/pubmed/26751038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep18996
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים